IL6 and rheumatoid arthritis: In conclusion, considering the existence of the interesting association between IL‐6 with various variables of CVD, SCORE and FRS, and screening cardiac biomarker in RA patients, IL‐6 may be considered a biomarker for the assessment of the risk for cardiovascular events in the subclinical stages of RA population.